======= RPRD1A =======
== Gene Information ==
* **Official Symbol**: RPRD1A
* **Official Name**: regulation of nuclear pre-mRNA domain containing 1A
* **Aliases and Previous Symbols**: N/A
* **Entrez ID**: [[https://www.ncbi.nlm.nih.gov/gene/?term=55197|55197]]
* **UniProt**: [[https://www.uniprot.org/uniprot/Q96P16|Q96P16]]
* **Interactions**: [[https://thebiogrid.org/search.php?search=RPRD1A&organism=9606|BioGRID]]
* **PubMed articles**: [[https://www.ncbi.nlm.nih.gov/pubmed/?term=gene%20RPRD1A|Open PubMed]]
* **OMIM**: [[https://omim.org/entry/610347|Open OMIM]]
== Function Summary ==
* **Entrez Summary**: N/A
* **UniProt Summary**: Interacts with phosphorylated C-terminal heptapeptide repeat domain (CTD) of the largest RNA polymerase II subunit POLR2A, and participates in dephosphorylation of the CTD by RPAP2. May act as a negative regulator of cyclin-D1 (CCND1) and cyclin-E (CCNE1) in the cell cycle. {ECO:0000269|PubMed:22231121, ECO:0000269|PubMed:24399136, ECO:0000269|PubMed:24997600}.
|DUF618|
|dephosphorylation of RNA polymerase II C-terminal domain|
|RNA polymerase II, holoenzyme|
|RNA polymerase II complex binding|
|snRNA transcription by RNA polymerase II|
|snRNA transcription|
|mRNA 3-end processing|
|ncRNA transcription|
|RNA 3-end processing|
|protein dephosphorylation|
|dephosphorylation|
|mRNA processing|
|transcription by RNA polymerase II|
|transcription, DNA-templated|
|nucleic acid-templated transcription|
|RNA biosynthetic process|
|mRNA metabolic process|
|RNA processing|
|nucleobase-containing compound biosynthetic process|
|heterocycle biosynthetic process|
|aromatic compound biosynthetic process|
|organic cyclic compound biosynthetic process|
|cellular nitrogen compound biosynthetic process|
|RNA metabolic process|
|cellular macromolecule biosynthetic process|
|macromolecule biosynthetic process|
|gene expression|
\\
=== CRISPR Data ===
^Screen^Score^
|[[:results:exp413|THZ531 0.11 to 0.175μM on day4 R07 exp413]]|-2.06|
|[[:results:exp412|THZ531 0.11 to 0.125 to 0.35μM on day4 then day6 R07 exp412]]|-1.93|
|[[:results:exp50|Nicotinamide 2000μM R01 exp50]]|-1.87|
|[[:results:exp355|Dinaciclib 0.007μM R07 exp355]]|-1.75|
|[[:results:exp410|THZ531 0.11 to 0.125μM on day4 R07 exp410]]|-1.74|
|[[:results:exp116|AICAR 240μM R03 exp116]]|1.72|
|[[:results:exp485|GSK626616 14μM R08 exp485]]|1.74|
|[[:results:exp218|A-395 10μM R05 exp218]]|1.87|
|[[:results:exp120|Dimethyl-Sulfoxide 1pc R03 exp120]]|1.95|
No correlation found to any other genes in chemogenomics.
Global Fraction of Cell Lines Where Essential: 0/739
^Tissue^Fraction Of Cell Lines Where Essential^
|1290807.0|0/1|
|909776.0|0/1|
|bile duct|0/28|
|blood|0/28|
|bone|0/26|
|breast|0/33|
|central nervous system|0/56|
|cervix|0/4|
|colorectal|0/17|
|esophagus|0/13|
|fibroblast|0/1|
|gastric|0/16|
|kidney|0/21|
|liver|0/20|
|lung|0/75|
|lymphocyte|0/16|
|ovary|0/26|
|pancreas|0/24|
|peripheral nervous system|0/16|
|plasma cell|0/15|
|prostate|0/1|
|skin|0/24|
|soft tissue|0/9|
|thyroid|0/2|
|upper aerodigestive|0/22|
|urinary tract|0/29|
|uterus|0/5|
== Essentiality in NALM6 ==
* **Essentiality Rank**: 3596
* **Expression level (log2 read counts)**: 6.46
{{:chemogenomics:nalm6 dist.png?nolink |}}